Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
18
RXRX Quote, Financials, Valuation and Earnings
Last price:
$6.05
Seasonality move
:
-18.3%
Day range:
$5.93 - $6.20
52-week range:
$5.60 - $15.74
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
22.96x
P/B ratio:
3.30x
Volume:
19.7M
Avg. volume:
14.4M
1-year change:
-36.21%
Market cap:
$1.7B
Revenue:
$43.9M
EPS (TTM):
-$1.55
Earnings Data
Next earnings date for RXRX
Feb 27
2025
Most recent earnings per share
-$0.34
Missed by $0.01
(Nov 6/2024)
Consensus Estimate
-$0.33
(Nov 6/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
RXRX Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/27/2025 | Q4 | $18.2M | -- | -- | -$0.41 | -- |
| 11/06/2024 | Q3 | $29.8M | $26.1M | -$0.34 | -$0.33 | -$0.01 |
| 08/08/2024 | Q2 | $13.3M | $14.4M | -$0.40 | -$0.38 | -$0.02 |
| 05/09/2024 | Q1 | $13.1M | $13.5M | -$0.39 | -$0.43 | $0.04 |
| 02/27/2024 | Q4 | $20.4M | $10.6M | -$0.42 | -$0.45 | $0.03 |
| 11/09/2023 | Q3 | -- | -- | -$0.43 | -$0.39 | -$0.04 |
| 08/08/2023 | Q2 | -- | -- | -$0.38 | -$0.37 | -$0.01 |
| 05/08/2023 | Q1 | -- | -- | -$0.34 | -$0.35 | $0.01 |
| 02/27/2023 | Q4 | -- | -- | -$0.31 | -$0.24 | -$0.07 |
| 11/08/2022 | Q3 | -- | -- | -$0.35 | -$0.38 | $0.03 |
| 08/09/2022 | Q2 | -- | -- | -$0.38 | -$0.37 | -$0.01 |
| 05/10/2022 | Q1 | -- | -- | -$0.33 | $0.51 | -$0.84 |
| 03/23/2022 | Q4 | -- | -- | -$0.38 | -$0.31 | -$0.07 |
| 11/10/2021 | Q3 | -- | -- | -$0.28 | -$0.28 | $0.00 |
| 08/13/2021 | Q2 | -- | -- | -$0.31 | -$0.24 | -$0.07 |
| 03/31/2021 | Q1 | -- | -- | -$0.20 | -$0.23 | $0.04 |
| 12/31/2020 | Q4 | -- | -- | -$0.23 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$0.17 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$0.16 | -- | -- |
Recursion Pharmaceuticals Earnings Questions
-
How Much did Recursion Pharmaceuticals Generate in Revenue Last Quarter?
Recursion Pharmaceuticals reported $26.1M worth of top line sales in its most recent quarter.
-
Did Recursion Pharmaceuticals Beat Earnings Last Quarter?
Recursion Pharmaceuticals announced earnings per share of -$0.34 which represents a miss of analyst forecast a -$0.33 per share.
-
Is Recursion Pharmaceuticals Profitable?
Recursion Pharmaceuticals reported $14M that represents $0.05 per share over the last quarter.
-
What is the Analyst Consensus for Recursion Pharmaceuticals EPS Next Year?
Recursion Pharmaceuticals's earnings are forecast to decrease from -$1.58 per share to -$1.65 per share next year representing a decrease of -5.54%.
-
When is Recursion Pharmaceuticals's Earnings Date?
Recursion Pharmaceuticals's next earnings date is February 27, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
